Bruno Bruins
Directeur/Membre du Conseil chez Institute for Translational Vaccinology
Profil
Bruno Bruins is currently a Member-Supervisory Board at the Institute for Translational Vaccinology and at Intravacc BV.
He previously served as the Minister for Medical Care in the Government of the Netherlands.
Postes actifs de Bruno Bruins
| Sociétés | Poste | Début |
|---|---|---|
Institute for Translational Vaccinology
 Institute for Translational Vaccinology BiotechnologyHealth Technology Institute for Translational Vaccinology is a Dutch independent company that partners with clients in vaccine development, from discovery to pilot production to clinical studies. The non-profit company is based in Bilthoven, Netherlands. Intravacc designs and creates the best candidate organisms for vaccine strain, looking for the highest immunity, potency, and production yield. The company substantially reduces the risks and costs involved with developing vaccines by bridging the gap between concept and late-stage clinical studies. Intravacc's upstream processing expertise covers both bacterial and cell cultivation as well as virus propagation in reactors ranging from 1l up to 200l. The company's scientists design, develop, and improve vaccine formulations that are suitable for the intended administration route and stable upon storage. | Directeur/Membre du Conseil | 01/01/2021 |
| Intravacc BV | Directeur/Membre du Conseil | 01/01/2021 |
Anciens postes connus de Bruno Bruins
| Sociétés | Poste | Fin |
|---|---|---|
| Government of the Netherlands | Ministre du Gouvernement | 19/03/2020 |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
| Government of the Netherlands | Government |
Institute for Translational Vaccinology
Institute for Translational Vaccinology BiotechnologyHealth Technology Institute for Translational Vaccinology is a Dutch independent company that partners with clients in vaccine development, from discovery to pilot production to clinical studies. The non-profit company is based in Bilthoven, Netherlands. Intravacc designs and creates the best candidate organisms for vaccine strain, looking for the highest immunity, potency, and production yield. The company substantially reduces the risks and costs involved with developing vaccines by bridging the gap between concept and late-stage clinical studies. Intravacc's upstream processing expertise covers both bacterial and cell cultivation as well as virus propagation in reactors ranging from 1l up to 200l. The company's scientists design, develop, and improve vaccine formulations that are suitable for the intended administration route and stable upon storage. | Health Technology |
| Intravacc BV | Health Technology |
